IVVD Invivyd Inc

Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it will present at the following investor conferences:

Morgan Stanley 22nd Annual Global Healthcare ConferenceFireside Chat Date: Friday, September 6, 2024Fireside Chat Time: 10:00 AM ETLocation: New York, NY

H.C. Wainwright 26th Annual Global Investment ConferenceFireside Chat Date: Monday, September 9, 2024Fireside Chat Time: 9:30 AM ETLocation: New York, NY

2024 Cantor Global Healthcare ConferenceFireside Chat Date: Wednesday, September 18, 2024Fireside Chat Time: 10:55 AM ETLocation: New York, NY

Live webcasts of the fireside chats will be available in the investor section of the company’s website at investors.invivyd.com and will be archived for approximately 90 days following the events.

About InvivydInvivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. The company’s proprietary INVYMAB™ platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to address evolving viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.

Contacts:

Media Relations(781) 208-0160media@invivyd.com

Investor Relations(781) 208-0160investors@invivyd.com